PCI BIOTECH HOLDING ASA (PCIB.OL) Stock Cash Flow
Europe - Euronext Oslo - OSL:PCIB - NO0010405640 - Common Stock
0.288 NOK
+0.03 (+10.34%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -16.42M | -20.32M | -55.09M | -88.39M | -72.24M | |||
| Depreciation Amortization | 303.00K | 371.00K | 6.41M | 2.54M | 2.21M | |||
| Change In Working Capital | 1.47M | 2.97M | -8.94M | 2.04M | -5.25M | |||
| Other non cash items | 885.00K | 2.00M | -1.41M | 15.51M | -2.11M | |||
| OPERATING CASH FLOW | -13.76M | -14.97M | -59.04M | -68.31M | -77.39M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | 0.00 | -341.00K | -3.92M | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | N/A | 0.00 | 0.00 | -341.00K | -3.92M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -357.00K | -442.00K | -678.00K | -673.00K | -668.00K | |||
| Stock Issued/Repurchased | N/A | 0.00 | N/A | 0.00 | 316.00K | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -357.00K | -442.00K | -678.00K | -673.00K | -352.00K | |||
| Exchange Rate Effect | N/A | 0.00 | 198.00K | -2.53M | 8.53M | |||
| CHANGE IN CASH | -14.12M | -15.41M | -59.52M | -71.85M | -73.14M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.76M | -14.97M | -59.04M | -68.31M | -77.39M | |||
| Capital Expenditure | N/A | 0.00 | 0.00 | -341.00K | -3.92M | |||
| FREE CASH FLOW | -13.76M | -14.97M | -59.04M | -68.65M | -81.31M | |||
All data in NOK